Making it matter: How GCCs transform capability into end patient impact examines the rapid evolution of healthcare and life sciences Global Capability Centers (GCCs in India) from efficiency driven support units into enterprise critical innovation hubs delivering measurable patient impact. Drawing from insights industry analysis, and case studies within the discussion paper, the report highlights how India has emerged as a strategic nucleus for global healthcare transformation-combining deep domain expertise, advanced digital capabilities, and scale to accelerate outcomes across the value chain.
There is a structural shift in global operating models across pharmaceuticals, life sciences, healthtech, and medical devices. India based GCCs are increasingly adopting a core first approach, taking ownership of high value mandates spanning R&D, clinical development, regulatory operations, product engineering, data platforms, and digital health. Rather than acting as downstream execution centers, these GCCs now lead end-to-end workflows and global platforms that directly influence speed to market, safety, access, and affordability of therapies, devices, and digital care solutions.
A defining strength of the discussion paper is its focus on making impact visible. Through a series of select case studies, the report shows how GCCs have compressed development cycles, automated regulatory submissions, optimized clinical trials, and enabled product innovation that reaches patients faster and at global scale. The paper also positions GCCs within a broader ecosystem of academia, startups, hospitals, government bodies, and industry clusters, reinforcing India’s position as a long term anchor for healthcare and life sciences innovation.
